这期的 The Economist：
Even with all these alleged errors, the controversy might have been
relegated to an arcane debate in the scientific literature if the team at
Duke had not chosen, within a few months of the papers’ publication (and at
the time questions were being raised about the data’s quality) to launch
three clinical trials based on their work. http://www.economist.com/node/21528593
